TransGlobal Assets Inc. (TMSH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 26, 2025, 3:23 PM EDT
TransGlobal Assets Market Cap
TransGlobal Assets has a market cap or net worth of $343.41 thousand as of August 26, 2025. Its market cap has decreased by -16.86% in one year.
Market Cap
343.41K
Enterprise Value
n/a
Revenue
91.35K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 11, 2008, TransGlobal Assets's market cap has decreased from 7.54M to 343.41K, a decrease of -95.45%. That is a compound annual growth rate of -16.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 343.41K | -5.18% |
| Dec 30, 2024 | 362.18K | 4.39% |
| Dec 29, 2023 | 346.93K | 6.46% |
| Dec 30, 2022 | 325.89K | -78.28% |
| Dec 31, 2021 | 1.50M | -11.89% |
| Dec 31, 2020 | 1.70M | -33.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 586.30M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |